156 related articles for article (PubMed ID: 14561437)
1. Influence of mirtazapine on urinary free cortisol excretion in depressed patients.
Schule C; Baghai T; Rackwitz C; Laakmann G
Psychiatry Res; 2003 Oct; 120(3):257-64. PubMed ID: 14561437
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
[TBL] [Abstract][Full Text] [Related]
3. Influence of mirtazapine on salivary cortisol in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
Bech P
Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
[TBL] [Abstract][Full Text] [Related]
6. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
Høyberg OJ; Maragakis B; Mullin J; Norum D; Stordall E; Ekdahl P; Ose E; Moksnes KM; Sennef C
Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
[TBL] [Abstract][Full Text] [Related]
7. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
Schüle C; Sighart C; Hennig J; Laakmann G
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1015-9. PubMed ID: 16644086
[TBL] [Abstract][Full Text] [Related]
10. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.
Shen J; Chung SA; Kayumov L; Moller H; Hossain N; Wang X; Deb P; Sun F; Huang X; Novak M; Appleton D; Shapiro CM
Can J Psychiatry; 2006 Jan; 51(1):27-34. PubMed ID: 16491981
[TBL] [Abstract][Full Text] [Related]
11. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Fava M; Rush AJ; Wisniewski SR; Nierenberg AA; Alpert JE; McGrath PJ; Thase ME; Warden D; Biggs M; Luther JF; Niederehe G; Ritz L; Trivedi MH
Am J Psychiatry; 2006 Jul; 163(7):1161-72. PubMed ID: 16816220
[TBL] [Abstract][Full Text] [Related]
12. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
14. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine-induced manic switch in adolescent unipolar depression.
Goyal N; Sinha VK
Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
[No Abstract] [Full Text] [Related]
17. Mirtazapine for depression in patients with human immunodeficiency virus.
Elliott AJ; Roy-Byrne PP
J Clin Psychopharmacol; 2000 Apr; 20(2):265-7. PubMed ID: 10770469
[No Abstract] [Full Text] [Related]
18. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
20. The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects.
Schüle C; Baghai T; Goy J; Bidlingmaier M; Strasburger C; Laakmann G
Psychopharmacology (Berl); 2002 Aug; 163(1):95-101. PubMed ID: 12185405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]